Myriad Genetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.About MYGN
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.
CEOSamraat S Raha
CEOSamraat S Raha
Employees2,700
Employees2,700
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded1991
Founded1991
Employees2,700
Employees2,700
MYGN Key Statistics
Market cap625.00M
Market cap625.00M
Price-Earnings ratio-1.55
Price-Earnings ratio-1.55
Dividend yield—
Dividend yield—
Average volume851.81K
Average volume851.81K
High today$7.18
High today$7.18
Low today$6.62
Low today$6.62
Open price$7.02
Open price$7.02
Volume759.59K
Volume759.59K
52 Week high$15.47
52 Week high$15.47
52 Week low$3.76
52 Week low$3.76
Stock Snapshot
Myriad Genetics(MYGN) stock is priced at $6.70, giving the company a market capitalization of 625M. It carries a P/E multiple of -1.55.
As of 2025-12-18, Myriad Genetics(MYGN) stock has fluctuated between $6.62 and $7.18. The current price stands at $6.70, placing the stock +1.3% above today's low and -6.7% off the high.
Myriad Genetics(MYGN) shares are trading with a volume of 759.59K, against a daily average of 851.81K.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $15.47 and a 52-week low of $3.76.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $15.47 and a 52-week low of $3.76.
Analyst ratings
54%
of 13 ratingsBuy
23.1%
Hold
53.8%
Sell
23.1%
People also own
Based on the portfolios of people who own MYGN. This list is generated using Robinhood data, and it’s not a recommendation.